Navigation Links
ACRES Names Katherine Madigan VP for Global Alliances and Advocacy
Date:11/30/2013

(PRWEB) November 30, 2013

ACRES, the Alliance for Clinical Research Excellence and Safety, a collaborative non-profit organization building a global system for clinical research, has named Katherine Madigan, MHSA, as its new Vice-President for Global Alliances and Advocacy.

Ms. Madigan brings in-depth knowledge of the clinical research enterprise and organizational development to ACRES. She previously led the Association of Clinical Research Organizations (ACRO) as Senior Vice President, where she directed the business operations and international lobbying activities on behalf of the global clinical outsourcing industry.

Prior to ACRO, she served as Director of Government Affairs & Special Projects at the Association of Clinical Research Professionals (ACRP), an ACRES strategic ally, founding the organization’s government affairs practice and focusing on international coalition building. Madigan concurrently served as Managing Director of the Academy of Physicians in Clinical Research, an ACRP affiliate, responsible for governance and strategic development for the physician-only organization. Her experience also includes public policy analysis and development in the office of Robert Merrifield, member of the Canadian Parliament, where she developed drug safety initiatives for Health Canada, and in 2001 she studied public opinion of stem cell research within the Office of the Agency Liaison at The White House under President George W. Bush.

“We are thrilled to have Ms. Madigan join the ACRES leadership team”, said Dr. Greg Koski, ACRES President and CEO. “An individual with the unique range of experiences in public policy, regulatory affairs, organizational management, networking and communications across the entire world of clinical research is simply invaluable—she knows how to build meaningful relationships, and we intend to put her knowledge and skills to work immediately”, he added.

In her new roll, Madigan will assume overall responsibility for building and managing the ACRES Alliance, a global collaborative of like-minded organizations, sponsors, CROs, service providers and advocacy groups committed to promoting safety, quality, efficiency and integrity in clinical research. ACRES has already established several strategic relationships with organizations that share a commitment to creating and implementing integrated systems solutions for the global clinical research enterprise that benefit all stakeholders.

In addition to her roll at ACRES, Madigan is a Principal of Madigan Partners, a professional services firm serving the life sciences and defense industries. She provides international development, advocacy and public affairs representation for clients, with focus in North America, the European Union/EEA and Asia. Her fields of specialty include healthcare, drug and device development, clinical trials, data privacy/protection, and security. Ms. Madigan graduated with a Bachelor of Arts in political science from the University of Michigan, where she also received a Masters in Health Services Administration and Public Health. She is an active member of the Junior League of Washington D.C. and the American Association of Medical Society Executives, most recently holding leadership positions as Public Relations Chair and Member of the Leadership Academy Board.

Read the full story at http://www.prweb.com/releases/GregKoskiACRES/MadiganVP/prweb11380735.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinical Research Site-Expert Johan Karlberg to Lead ACRES Global Network Development
2. ACRES and PharmaTrain Announce Strategic Alliance
3. ACRES Announces Strategic Alliance with Atlantis Global Research Institute
4. ACRES Launches Global Clinical Research Network Technology Platform
5. ISPE Names Dr. Thomas Zimmer as Vice President of European Operations
6. Juneau Biosciences Names Dr. Dinesh Patel to Board of Directors
7. Vaccinogen Names Dr. Benjamin Carson and Dr. Jan B. Vermorken to Medical Advisory Board
8. Biosimilars Need Same Names as Original Biologics, Hospira Says at World Health Organization (WHO) Meeting
9. Genera Energy Names Sam Jackson VP of Business Development
10. Adheron Therapeutics Names New Senior Leadership
11. Golden West Biologicals Names Matriks as Distribution Partner in Norway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... ... A microbiome impact grant award has been made to Dr. Renato Polimanti of ... and drinking on the oral microbiome. Grant proposals have been vetted by the ...
(Date:12/2/2016)... ... 02, 2016 , ... In anticipation of AxioMed’s exclusive cleanroom ... company President, Jake Lubinski will be traveling to Switzerland from December 5-10. Mr. ... Lucerne, and Zurich to discuss the benefits of a viscoelastic disc. AxioMed received ...
(Date:12/2/2016)... Dec. 2, 2016 Amgen (NASDAQ: AMGN ... announced the submission of a Marketing Authorization Application (MAA) to ... candidate to Avastin ® (bevacizumab). The companies believe this ... EMA. "The submission of ABP 215 to ... expand our oncology portfolio," said Sean E. Harper , ...
(Date:12/2/2016)... ... December 01, 2016 , ... ACEA Biosciences, Inc. announced today that it will ... AC0010 at the World Conference on Lung Cancer 2016, taking place in Vienna, Austria ... I/II clinical trials for AC0010 in patients with advanced non-small cell lung cancer harboring ...
Breaking Biology Technology:
(Date:6/22/2016)... 2016 On Monday, the Department of Homeland ... share solutions for the Biometric Exit Program. The Request ... Protection (CBP), explains that CBP intends to add biometrics ... the United States , in order to deter ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... 9, 2016  Perkotek an innovation leader in attendance control systems is proud to ... hours, for employers to make sure the right employees are actually signing in, and ... ... ... ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):